Take a look at a great article that was published today in Nature describing how the Division of Signal Transduction Therapy (DSTT) enables pre-competitive access to ubiquitin system research at the University of Dundee.
Our friends at the University of Dundee continue to forge ahead in the ubiquitin field supported in part by this DSTT pharmaceutical company consortia.
Ubiquigent is pleased to be part of this rapidly developing ubiquitin system-focused research hub in Dundee. We look forward to helping more and more groups exploit the ubiquitin system by providing access to a focused collection of Drug Discovery Services, Research Tools and Chemistry services. If you're interested in learning more about the ubiquitin system or any of our capabilities we'd be pleased to hear from you.